About Pierre Fabre
Pierre Fabre is a company based in Castres (France) founded in 1962. Pierre Fabre has completed 3 acquisitions, including Glytone, MÊME and Vertical Bio. Pierre Fabre offers products and services including Prescription Drugs and Dermo-Cosmetics Products.
- Latest Funding Round$482.54K (USD), Grant
Apr 2021
- InvestorsEuropean Union
& 1 more
- Investments & AcquisitionsGlytone
& 2 more
Products & Services of Pierre Fabre
Pierre Fabre offers a comprehensive portfolio of products and services, including Prescription Drugs and Dermo-Cosmetics Products.
Prescription drugs are developed and distributed for the treatment of chronic diseases and oncology, with a focus on advancing therapies for unmet needs
Dermo-cosmetics products are created for skin and hair care, incorporating brands like Avène and Klorane to address dermatological concerns
Apps and channels of Pierre Fabre
its YouTube channel Pierre Fabre Group has 1.08K subscribers and 30 videos.
Videos from Pierre Fabre
The most watched videos on Pierre Fabre's YouTube channel, Pierre Fabre Group (1.08K subscribers). Click a video to play it here.
More on Pierre Fabre Group.
Funding Insights of Pierre Fabre
- Total Rounds 3
- Last Round Grant — $482,544
- Investors Count 2
All 3 funding rounds of Pierre Fabre with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $482,544 | Grant | – | – | |
| Mar 2021 | $418,390 | Grant | – | – | |
| Jan 2015 | – | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Pierre Fabre
Pierre Fabre has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | economie.gouv.fr | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Pierre Fabre
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pierre Fabre
554 people are tracked at Pierre Fabre (134 in leadership, 10 in board & advisors, 410 in team).
| Name | Role | Group |
|---|---|---|
Monika Miodek-Huber | Head Of Customer And Shopper Marketing Ecom & Stationary | Leadership |
Olivier Verjat | CFO - Operation Director Korea & Japan & Vietnam | Leadership |
Eric Gouy | CFO & Legal Affairs | Leadership |
Frédéric Ennabli | Cosmetics CEO | Leadership |
Fernando Junoy | Managing Director, Pierre Fabre International | Leadership |
George Sciacca | Sr Human Resources Business Partner - Pharma | Leadership |
Art Nimbley | Director Of IT | Leadership |
Diana Manolova | General Manager | Leadership |
Emmanuel Simioni | Head Of Operation APAC | Leadership |
Hernan Fernandez | Regional HR Director - HRBP Americas | Leadership |
Oliver Wenzel | Head Of Ecommerce & Emarketplaces | Leadership |
Cyril Beaudoux | Digital Project Director (international) | Leadership |
Olga Denisova | Business Unit Director / Sales & Marketing Director | Leadership |
Umit D. | Head Of Operations | Leadership |
Carlos Cunha | Head Of Digital DCPC & Media Manager MC | Leadership |
Angel Lye | Marketing Director - Eau Thermale Avène, A-derma, Klorane, Rene Furterer | Leadership |
Aline Perreu | Human Resources Director, USA | Leadership |
Anne-Laure Pauzies | Digital & Transformation IT Director | Leadership |
Cedric Faucher | Director Operational Excellence And Digital | Leadership |
Ricardo Lopes | Country CFO | Leadership |
534 more people are available in the full profile.
Complete people profiles for Pierre Fabre
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pierre Fabre
Pierre Fabre has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Glytone, MÊME and Vertical Bio.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Monoclonal antibodies targeting c-MET for lung cancer treatment are developed. | verticalbioag.tcc.mode | Basel, Switzerland | 2021 | Sep 2023 | •••• | |
Natural dermo-cosmetics are developed for sensitive skin by MÊME. | memecosmetics.fr | Paris, France | 2015 | Apr 2023 | •••• | |
Glytone is recognized for offering professional skin care products. | glytone.com | Parsippany, United States | 1996 | Jun 2022 | •••• |
Complete acquisition details for Pierre Fabre
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Pierre Fabre
6 dated milestones of Pierre Fabre across 61 years, from founding to its latest funding, stage changes and deals.
- Founded Pierre Fabre is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $483K.
- Acquisition Acquires Glytone.
- Acquisition Acquires MÊME.
- Acquisition Acquires Vertical Bio.
Web traffic of Pierre Fabre
The website of Pierre Fabre (pierre-fabre.com) receives about 125.2K visits a month and ranks #237,153 among all websites worldwide, #7,899 in Biotechnology and Pharmaceuticals.
- Monthly visits125.2K
▼ 14.9% vs previous month
- Unique visitors59.5K
per month
- Global rank#237,153
among all websites
- Category rank#7,899
Health · Biotechnology and Pharmaceuticals
- Bounce rate33%
- Pages per visit3.4
- Average visit1 min 14 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Pierre Fabre. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
baxter.fr | baxter.fr | 100% | – | #8,347,958 | – |
| lecomptoirdespharmacies.fr | 93% | 38.5K | #456,952 | View details | |
roche.fr | roche.fr | 91% | – | #533,892 | – |
| grunenthal.com | 90% | 37.5K | #834,989 | View details | |
| celgene.com | 90% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Pierre Fabre
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Pierre Fabre
10 companies that operate in the same segment as Pierre Fabre (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pierre Fabre
Pierre Fabre was founded in 1962 and raised its 1st funding round 53 years after it was founded.
Pierre Fabre is headquartered in Castres, France. It is registered at Castres, Occitanie, France.
Pierre Fabre was founded in 1962 in Castres, France, with operations focused on pharmaceuticals and consumer healthcare. Therapeutic areas addressed include oncology, gynecology, neuropsychiatry, urology, cardiology, and diabetes. Consumer products are developed for oral care, nicotine replacement therapy, and dermatology. Ownership extends to dermo-cosmetic brands such as Klorane, Avene, Ducray, and Elancyl, supporting global distribution.
Pierre Fabre offers Prescription Drugs and Dermo-Cosmetics Products.
Pierre Fabre has made 3 acquisitions, including Glytone, MÊME, and Vertical Bio.
Pierre Fabre has 2 investors. Key investors include European Union, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
Pierre Fabre operates through Pierre Fabre Laboratories.
The website of Pierre Fabre receives about 125 thousand visits a month and ranks #237,153 among all websites worldwide.